Iridex (NASDAQ: IRIX) meets Nasdaq $2.5M equity requirement

Rhea-AI Filing Summary

IRIDEX Corporation reports that it has regained compliance with Nasdaq’s continued listing standards. Based on its Form 10-Q for the quarter ended June 28, 2025, the company now meets the Nasdaq Listing Rule 5550(b)(1) minimum stockholders’ equity requirement of $2,500,000 for the Nasdaq Capital Market.

Nasdaq has informed IRIDEX that the prior non-compliance matter is closed, removing the earlier listing deficiency. The company also issued a press release on September 9, 2025 to highlight its renewed compliance with the stockholders’ equity requirement.

Positive

• Nasdaq compliance restored: Nasdaq confirmed IRIDEX now meets the $2,500,000 minimum stockholders’ equity requirement under Listing Rule 5550(b)(1), closing a prior non-compliance notice and reducing listing-status risk.

Negative

• None.

Insights

Equity & Listing Standards Analyst

IRIDEX has resolved its Nasdaq equity listing deficiency and closed the compliance matter.

IRIDEX previously received a Nasdaq notice for failing to meet the Nasdaq Listing Rule 5550(b) continued listing standards tied to financial criteria. Using updated figures from its June 28, 2025 Form 10-Q, the company now satisfies the minimum $2,500,000 stockholders’ equity threshold under Rule 5550(b)(1) for the Nasdaq Capital Market.

Nasdaq’s written notice that the company has regained compliance and that the matter is closed removes an overhang related to potential delisting. A press release dated September 9, 2025 was issued to communicate this status change, and future periodic reports will indicate whether IRIDEX continues to meet the equity requirement.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false000100604500010060452025-08-272025-08-27

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	August 27, 2025
Date of Report (date of earliest event reported)
IRIDEX CORPORATION
(Exact name of registrant as specified in its charter)
Delaware		000-27598	77-0210467
(State or other jurisdiction of incorporation or organization)		(Commission File Number)	(I.R.S. Employer Identification Number)
1212 Terra Bella Avenue Mountain View, California 94043
(Address of principal executive offices, including zip code)
(650) 940-4700
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of Class		Trading Symbol		Name of Exchange on Which Registered
Common Stock, par value $0.01 per share		IRIX		Nasdaq Capital Market

Item 8.01. Other Events.

As previously reported, on May 14, 2025, IRIDEX Corporation (the “Company”) received a notification of non-compliance (the “Notice”) from Nasdaq’s Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon its Quarterly Report on Form 10-Q for the quarterly period ended March 29, 2025 that was filed with the Securities and Exchange Commission (the “SEC”) on May 13, 2025, the Company was not in compliance with the continued listing standards set forth in Nasdaq Listing Rule 5550(b).

On August 27, 2025, the Company received written notice from Nasdaq informing the Company that, based upon its Quarterly Report on Form 10-Q for the quarterly period ended June 28, 2025 that was filed with the SEC on August 12, 2025, the Company has regained compliance with the continued listing standards of Nasdaq Listing Rule 5550(b) by satisfying the minimum stockholders’ equity requirement of $2,500,000 for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”), and that the matter is now closed.

On September 9, 2025, the Company issued a press release regarding its regained compliance with the Stockholders’ Equity Requirement. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release dated September 9, 2025.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			IRIDEX CORPORATION
	By:		/s/ PATRICK MERCER
			Patrick Mercer
			Chief Executive Officer
Date: September 9, 2025

-3-

FAQ

What did IRIDEX Corporation (IRIX) announce regarding its Nasdaq listing status?

IRIDEX announced it has regained compliance with Nasdaq’s continued listing standards. Nasdaq confirmed the company now meets the stockholders’ equity requirement, and the earlier non-compliance matter under Listing Rule 5550(b) is considered closed.

Which specific Nasdaq rule did IRIDEX (IRIX) return to compliance with?

IRIDEX returned to compliance with Nasdaq Listing Rule 5550(b)(1). This rule requires a minimum of $2,500,000 in stockholders’ equity for companies listed on the Nasdaq Capital Market, which IRIDEX now satisfies based on its latest Form 10-Q.

What minimum stockholders’ equity level does IRIDEX (IRIX) now meet for Nasdaq?

IRIDEX now meets the Nasdaq Capital Market’s minimum stockholders’ equity requirement of $2,500,000. Nasdaq’s notice confirms this equity level satisfies Listing Rule 5550(b)(1), restoring the company’s compliance with continued listing standards after a prior deficiency notice.

How did IRIDEX (IRIX) demonstrate regained compliance with Nasdaq’s standards?

IRIDEX demonstrated regained compliance through its Form 10-Q for the quarter ended June 28, 2025. Nasdaq reviewed this filing, concluded the company meets the $2,500,000 stockholders’ equity requirement, and formally notified IRIDEX that the listing deficiency matter is closed.

Did IRIDEX (IRIX) communicate its renewed Nasdaq compliance to investors?

Yes. IRIDEX issued a press release dated September 9, 2025 to highlight that it has regained compliance with Nasdaq Listing Rule 5550(b)(1). The release, filed as Exhibit 99.1, informs investors that Nasdaq has closed the prior non-compliance matter.